Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Explore how pharmaceutical regulations shape drug development, marketing authorization, GMP requirements, and pharmacovigilance across major markets. This guide explains global regulatory frameworks, approval pathways, compliance expectations, and inspection readiness for pharmaceutical companies operating under changing regulatory requirements.
A planned expansion of Regeneron’s flagship Eylea HD product has been rejected by the US FDA after a key fill-finish manufacturing site failed to meet GMP inspection standards, triggering a full regulatory setback and delaying a major lifecycle upgrade.